Skip to content
Dose Brief
Menu
No. 281 on the board · Grade C

OrderlyMeds review

Telehealth provider offering one of the lowest 3-month starter prices for compounded GLP-1 medications.

Visit OrderlyMeds Assume any provider we list may compensate us — we may earn a commission, at no cost to you. It never changes the score.
Semaglutide
From $74/mo (starting dose, 3-month plan, compounded)
Tirzepatide
From $299/mo (compounded)
Coverage
Coverage not published
Brand-name
Compounded only
On the trackerNewnew to the tracker, no prior readingNew to the tracker on 1 August 2026. The published line reads From $74/mo (starting dose, 3-month plan, compounded) at our first reading; there is no earlier reading of ours to compare it against yet.

The scorecard

OrderlyMeds scored on our six Brief Score factors. See the methodology.

Price Stability36/100
Supply Reliability74/100
Transparency72/100
Access Breadth50/100
Clinical Oversight82/100
Track Record73/100

What we like

  • Aggressively low monthly pricing
  • Both semaglutide and tirzepatide available
  • Compounded GLP-1 access

The caveats

  • Limited public information on program details

The brief

Best for: Readers who want budget-conscious shoppers. Telehealth provider offering one of the lowest 3-month starter prices for compounded GLP-1 medications.

Ranked #281 of 495 providers we reviewed — see our #1 pick, CoreAge Rx, for comparison.

Closest on the board

The desks scoring nearest OrderlyMeds — the realistic shortlist if you're weighing it.

Weighing OrderlyMeds against one desk in particular? We file it head to head with our top-ranked pick in CoreAge Rx vs OrderlyMeds, and every desk that outranks it is listed on the OrderlyMeds alternatives board.

More desks we track (24)

464 more are filed too — see every desk we track, ranked.

Pricing, states and verification reflect OrderlyMeds's public disclosures at last review; the Brief Score is our editorial judgment per the methodology. Prices change — confirm on OrderlyMeds's site. Not medical advice; see our disclosure.

← Back to all rankings